Dr Sebastian Robert Stanciu, MD - Medicare Internal Medicine in Jacksonville, FL

Dr Sebastian Robert Stanciu, MD is a medicare enrolled "Internal Medicine - Infectious Disease" physician in Jacksonville, Florida. He graduated from medical school in 1999 and has 25 years of diverse experience with area of expertise as Internal Medicine. He is a member of the group practice First Coast Infectious Disease Consultants Llc, Georgia Infectious Disease Consultants and his current practice location is 2122 University Blvd S, Jacksonville, Florida. You can reach out to his office (for appointments etc.) via phone at (904) 398-5614.

Dr Sebastian Robert Stanciu is licensed to practice in Florida (license number ME89939) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1730145608.

Contact Information

Dr Sebastian Robert Stanciu, MD
2122 University Blvd S,
Jacksonville, FL 32216-8937
(904) 398-5614
(904) 398-5617



Physician's Profile

Full NameDr Sebastian Robert Stanciu
GenderMale
SpecialityInternal Medicine
Experience25 Years
Location2122 University Blvd S, Jacksonville, Florida
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Sebastian Robert Stanciu graduated from medical school in 1999
  NPI Data:
  • NPI Number: 1730145608
  • Provider Enumeration Date: 04/21/2006
  • Last Update Date: 08/28/2019
  Medicare PECOS Information:
  • PECOS PAC ID: 5890727226
  • Enrollment ID: I20050907000526

Medical Identifiers

Medical identifiers for Dr Sebastian Robert Stanciu such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1730145608NPI-NPPES
G099441597OtherGAGEORGIA MEDICARE PALMETTO GBA
273691800MedicaidFL

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RI0200XInternal Medicine - Infectious Disease ME89939 (Florida)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Baptist Health Medical Center - JacksonvilleJacksonville, FLHospital
Orange Park Medical CenterOrange park, FLHospital
Mayo Clinic Health System In WaycrossWaycross, GAHospital
Memorial Hospital JacksonvilleJacksonville, FLHospital
Ascension St Vincent's RiversideJacksonville, FLHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
First Coast Infectious Disease Consultants Llc256755110418
Georgia Infectious Disease Consultants37798229522

News Archive

Cancer Therapeutics reveals proof of concept for second development drug

Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) platform for the identification of small molecule inhibitors of protein ubiquitination, a key element in the essential cellular process of protein homeostasis, which is an exciting new target pathway for cancer treatment. Both scientific developments will be presented as posters at the EACR conference in Barcelona Spain on July 7-10 2012.

Study shows trophon EPR effective in inactivating high-risk, cancer-causing HPV

A new study presented at the Society for Healthcare Epidemiology of America has demonstrated that the trophon EPR is the only high level disinfection system proven to kill natural, infectious, high-risk human papilloma virus (HPV) under normal use conditions.

CryoLife commences European distribution of PerClot polysaccharide hemostatic agent

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that it has begun European distribution of PerClot®, a novel polysaccharide hemostatic agent used to control bleeding during surgical procedures or following traumatic injuries.

Simple steps for better long-term eye health

A new year is a time for reprioritizing. To encourage consumers to make their eyes a priority this year, AllAboutVision.com has issued its 2012 Checklist for Better Vision & Eye Health.

Majority of consumers say food scoring system would influence their purchasing decisions

Grocery shoppers in a new study report that a one to 100-point food rating system would help them choose what goes into their carts.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Sebastian Robert Stanciu allows following entities to bill medicare on his behalf.
Entity NameFirst Coast Infectious Disease Consultants Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1740477843
PECOS PAC ID: 2567551104
Enrollment ID: O20071204000531

News Archive

Cancer Therapeutics reveals proof of concept for second development drug

Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) platform for the identification of small molecule inhibitors of protein ubiquitination, a key element in the essential cellular process of protein homeostasis, which is an exciting new target pathway for cancer treatment. Both scientific developments will be presented as posters at the EACR conference in Barcelona Spain on July 7-10 2012.

Study shows trophon EPR effective in inactivating high-risk, cancer-causing HPV

A new study presented at the Society for Healthcare Epidemiology of America has demonstrated that the trophon EPR is the only high level disinfection system proven to kill natural, infectious, high-risk human papilloma virus (HPV) under normal use conditions.

CryoLife commences European distribution of PerClot polysaccharide hemostatic agent

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that it has begun European distribution of PerClot®, a novel polysaccharide hemostatic agent used to control bleeding during surgical procedures or following traumatic injuries.

Simple steps for better long-term eye health

A new year is a time for reprioritizing. To encourage consumers to make their eyes a priority this year, AllAboutVision.com has issued its 2012 Checklist for Better Vision & Eye Health.

Majority of consumers say food scoring system would influence their purchasing decisions

Grocery shoppers in a new study report that a one to 100-point food rating system would help them choose what goes into their carts.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Sebastian Robert Stanciu is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Sebastian Robert Stanciu, MD
Po Box 55009,
Jacksonville, FL 32216-0009

Ph: (912) 335-6943
Dr Sebastian Robert Stanciu, MD
2122 University Blvd S,
Jacksonville, FL 32216-8937

Ph: (904) 398-5614

News Archive

Cancer Therapeutics reveals proof of concept for second development drug

Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ (bevacizumab – Genentech/Roche) in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening (HTS) platform for the identification of small molecule inhibitors of protein ubiquitination, a key element in the essential cellular process of protein homeostasis, which is an exciting new target pathway for cancer treatment. Both scientific developments will be presented as posters at the EACR conference in Barcelona Spain on July 7-10 2012.

Study shows trophon EPR effective in inactivating high-risk, cancer-causing HPV

A new study presented at the Society for Healthcare Epidemiology of America has demonstrated that the trophon EPR is the only high level disinfection system proven to kill natural, infectious, high-risk human papilloma virus (HPV) under normal use conditions.

CryoLife commences European distribution of PerClot polysaccharide hemostatic agent

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, announced today that it has begun European distribution of PerClot®, a novel polysaccharide hemostatic agent used to control bleeding during surgical procedures or following traumatic injuries.

Simple steps for better long-term eye health

A new year is a time for reprioritizing. To encourage consumers to make their eyes a priority this year, AllAboutVision.com has issued its 2012 Checklist for Better Vision & Eye Health.

Majority of consumers say food scoring system would influence their purchasing decisions

Grocery shoppers in a new study report that a one to 100-point food rating system would help them choose what goes into their carts.

Read more News

› Verified 6 days ago


Internal Medicine Doctors in Jacksonville, FL

Dr. Jami Ann Rothe Kinnucan, M.D.
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 4500 San Pablo Rd S, Jacksonville, FL 32224
Phone: 904-953-2000    
Michelle Tulang, MD
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 4500 San Pablo Rd S, Jacksonville, FL 32224
Phone: 904-953-2000    
Dr. Minnsun Koh Park, M.D.
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 3900 University Blvd S, Jacksonville, FL 32216
Phone: 904-222-6656    
Sandrela Mussallam Abu Shaibeh,
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 820 Prudential Dr Ste 304, Jacksonville, FL 32207
Phone: 904-202-3860    Fax: 904-202-3846
Krunal Patel, MD
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 4800 Belfort Rd, Jacksonville, FL 32256
Phone: 904-398-7205    Fax: 904-396-4047
Zaid Abdel Rahman, M.D.
Infectious Disease
Medicare: Medicare Enrolled
Practice Location: 4500 San Pablo Rd S, Jacksonville, FL 32224
Phone: 904-953-2000    
Sina O'sullivan, MD
Infectious Disease
Medicare: Accepting Medicare Assignments
Practice Location: 4500 San Pablo Rd S, Jacksonville, FL 32224
Phone: 904-953-2000    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.